GlassScriptPhysician profile
Joseph Mckenna
NPI 1760411599
$415.69
in general payments reported to CMS, 2019-2025
6 companies · $38.84 in 2025
The $38.84 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $24.12 · 2021: $43.46 · 2022: $19.37 · 2023: $63.76 · 2024: $52.93 · 2025: $38.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140 · Education: $15.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.31 |
| Education | $15.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $173.84 | 2019-2025 | Farxiga |
| Amgen INC. | $117.72 | 2019-2022 | |
| Travere Therapeutics, INC. | $67.89 | 2023-2024 | |
| Medtronic, INC. | $24.05 | 2025 | Symplicity G3 |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.97 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.22 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mckenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.